The company has been improving manufacturing processes and fixed costs over four years and could expect to see 8 to 10 percent free cash flow yield, according to the report.
Zimmer has also been investing in emerging markets, such as China and India.
More Articles on Devices:
American Spine Expands to Gettysburg
Miami Project to Cure Paralysis Successfully Transplants Human Cells for Spinal Cord Injury
Outlook for Spinal Non-Fusion Technology Trends: Q&A with Joe Ross of LDR
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.